receptor cross-linking and transduced via signaling motifs in the cytoplasmic domains of the Ig␣/Ig␤ heteroand Klaus Rajewsky Institute for Genetics dimer associated with both pBCR and BCR (Reth and Wienands, 1997) . While ablation of the cytoplasmic tail University of Cologne D-50931 Cologne of Ig␣ indeed impedes B cell development , the existence and nature of the ligands mediating Federal Republic of Germany receptor cross-linking at the developmental checkpoints is still hypothetical. One speculation is that B cell devel targeting, which has already been instrumental in the system also depends on BCR expression, we have identification of the early checkpoints in B cell developgenerated a transgenic mouse in which the BCR can ment, marked by the expression of pBCR and BCR, be inducibly ablated through V region gene deletion.
A third loxP site was placed downstream of the IgH E enhancer. The closed triangles represent the loxP sites. Structure of the targeted IgH locus that has incorporated the third loxP site (3), the locus after removal of the neo r gene (4), and the locus upon full deletion of the targeted loxP-flanked B1-8 VDJ-E fragment (5) are shown. The sizes of the restriction fragments as revealed by the probes after homologous recombination and each subsequent deletional event are indicated. (B) Southern blot analyses of ES cell clones. Genomic DNA from parental E14 cells and clone 69 that gave germline transmission of the modified IgH allele were digested with either BamHI, PstI, or HindIII and hybridized with probes (a), (b) , and (c), respectively. Probe (a) was used to verify the targeting event and subsequent deletion of the neo r gene. Probe (b) was used to detect the cointegration of the third loxP site. Finally, probe (c) distinguished subclones that had deleted only the neo r gene or the neo r gene and the entire loxP-flanked B1-8 VDJ-E fragment after transient transfection of homologous recombinants with a cre-expressing plasmid. Sizes of the wild-type and modified IgH loci are shown. (C) IgH allotype and idiotype expression on peripheral blood lymphocytes (PBL) from B1-8f/ϩ and control mice. PBLs of germline-transmitted chinchilla offspring obtained from crosses of chimeric E14-CB20 males and CB20 females were analyzed by flow cytometry for (a) IgH allotype and (b) B1-8 idiotype expression. E14-and CB20-derived B cells express a and b allotypes, respectively. PBLs were stained with FITC-antib and PE-antia or FITC-anti-IgM and biotin-Ac146 (anti-B1-8) MAbs. The latter is revealed by streptavidin-PE. Numbers indicate percentages of total lymphocytes. B1-8f/ϩ mice indicates that the majority of the B cells and E enhancer by two loxP sites has no deleterious effect on the expression of the Ig transgene. (Ͼ70%) express the Ac146 idiotype ( Figure 1C ). In addition, heterozygous mice carrying the B1-8f allele of the a allotype and a wild-type IgH allele of the b allotype exhibit perfect allelic exclusion of the latter. In these Induced Deletion of the Antigen Receptor on Mature B Cells mice, more than 95% of the B cells express surface Ig of the a allotype, in agreement with previous results To achieve induced deletion of the antigen receptor in B cells, B1-8f/ϩ mice were crossed with Mx-cre mice (Sonoda et al., 1997) . Together, these data indicate that essentially all B cells in B1-8f heterozygous or homozythat bear the Cre transgene under the control of type I interferon (IFN)-inducible Mx promoter (Kü hn et al., gous mice express the targeted Ig transgene. Furthermore, they show that the flanking of the V region gene 1995). In adult B1-8f/ϩ, Mx-cre mice, BCR expression ϫ10 5 ): 3.4 Ϯ 0.5 (d0), 5.0 Ϯ 2.6 (d3), 3.1 Ϯ 1.6 (d6), 5.9 Ϯ 2.6 (d10), 6.0 Ϯ 3.2 (d20). Abbreviations: (Spl), spleen; (BM), bone marrow; (PerC), peritoneal cavity; (LN), lymph nodes; and (d), day.
can be ablated by treatment of the animals with recombi-B1-8f/ϩ and B1-8f/ϩ, Mx-cre mice given phosphatebuffered saline (PBS) (data not shown). The IgM lo populanant ␣/␤ IFN. Because B cells in heterozygous B1-8f mice exhibit allelic exclusion and express only the tartion likely represents cells in which the B1-8f allele has been deleted but which still retain some Ig on the cell geted but not the wild-type IgH allele, the effect of the induced deletion of the floxed B1-8 transgene can be surface due to protein turnover. In the blood, IgM lo cells comprise approximately 15% of IgM ϩ cells 2 days after directly assessed at the level of BCR expression in these animals.
IFN treatment of B1-8f, Mx-cre mice, and this increases to 30% on day 6 before subsiding to background level As shown in Figure 2A , a population of B cells that expresses low level of IgM (IgM lo ) can be seen in the 2 weeks later (data not shown). Over time, as seen in the analysis of peripheral blood lymphocytes (PBL) on peripheral blood of B1-8f/ϩ, Mx-cre mice 2-3 days after injection of IFN. This population is absent in B1-8f/ϩ day 6 (Figure 2A ), there is a decrease in the proportion of recirculating B cells in the blood of these animals. control mice injected with IFN ( Figure 2A ) as well as in IgM lo cells can also be detected at early time points in the various lymphoid organs such as the spleen, bone marrow and peritoneal cavity ( Figure 2B ), and lymph nodes (data not shown, c.f. Figure 5A ) of IFN-treated B1-8f, Mx-cre mice.
B Cells without BCR Do Not Accumulate in the Periphery B1-8f/ϩ, Mx-cre mice were further crossed with J H T/J H T mice (in which both IgH alleles are inactivated [Gu et al., 1993] ) to derive B1-8f/JHT, Mx-cre offspring with one 1995; Schwenk et al., 1995) , that these events are not Similarly, very few B cells were present in the mesenteric detrimental to mammalian cells in general and thus, are and inguinal lymph nodes 10 days after IFN injection, unlikely to be the cause of the disappearance of B lymand the number of splenic B cells was also substantially phocytes that had deleted the B1-8f allele. reduced ( Figure 2C ). Quantification of Ig ϩ cells in IFNAnother possibility for the disappearance of mutant treated B1-8f/J H T, Mx-cre mice indicates that the loss B cells could be due to the accumulation of aberrant of B cells was rapid in that the number of B lymphocytes C protein from the deleted B1-8f allele, which could was significantly reduced (Ͼ60%) 10 days after IFN inbe toxic to the cells. However, we consider this unlikely, jection. There were approximately 20% Ig ϩ B cells left as deletion of the E enhancer in vivo prevents C tranin the spleen and between 5% and 15% B cells left in scripts from being made (Gu et al., 1993) . the lymph nodes ( Figure 2C ) 20 days after IFN treatment.
To show that the loss of peripheral B cells in IFNThe loss of B cells in the peritoneal cavity, however, treated B1-8f/J H T, Mx-cre mice is indeed due to lack of was more gradual, perhaps reflecting a higher expres-BCR expression, we generated mice that carry distinct sion level and/or a slower turnover of sIg on these cells.
VHDHJH insertions in their two IgH alleles, only one of Flow cytometric analyses using two surface markers which can be inducibly deleted. In such mice, most B (B220 and CD19) that are expressed on B-lineage cells cells express H chains from both IgH alleles (Sonoda et revealed that there was no accumulation of B220 ϩ IgM Ϫ al., 1997). Therefore, the loss of one IgH allele upon IFN or CD19
ϩ IgM Ϫ cells in the peripheral blood or lymphoid injection should still allow BCR expression and the cells organs of IFN-induced B1-8f/J H T, Mx-cre mice over time should survive as "single producers." (Figures 2A and 2B) , suggesting that such cells do not B1-8f/ϩ, Mx-cre mice were crossed with glD42i/ϩ survive in vivo. This was confirmed by Southern blot mice that carry a distinct functional "knock-in" V H D H J H analysis of purified splenic cells depleted of T cells and segment to derive B1-8f/glD42i, Mx-cre offspring. As macrophages from B1-8f/J H T, Mx-cre mice at various expected (Sonoda et al., 1997) , most B cells in such times after IFN injection. As seen in Figure 3 , purified B mice are allelically "included" and express both heavy cells obtained 2-5 days after IFN induction were enchain proteins on the cell surface, distinguishable from riched for cells bearing the deleted Ig transgene. Howeach other by their constant region allotypes (B1-8f, a, ever, over time, these cells disappeared and were suband glD42i, b). stituted by B cells in which the floxed Ig transgene had B1-8f/glD42i, Mx-cre and B1-8f/glD42i control mice not been deleted by IFN treatment. In contrast, most T were first given anti-interleukin 7 receptor antibody cells obtained from B1-8f/J H T, Mx-cre mice from day 6 (anti-IL7R MAb) to block B lymphopoiesis in the bone to day 20 after IFN injection harbored only the deleted marrow (Sudo et al., 1993) . This is to simplify the analysis B1-8f allele. These cells persist because the BCR is not of B cells in the periphery by preventing the generation expressed in and not essential for T-lineage cells.
of new single IgH-expressing B cells in the bone marrow after IFN-induced deletion of the B1-8f allele.
Loss of Peripheral B Cells Is Due to Loss
Before induction of cre expression, the majority of the of BCR Expression B cells in B1-8f/glD42i, Mx-cre mice coexpress both IgH The disappearance of peripheral B cells in IFN-treated B1-8/J H T, Mx-cre mice could be due to the sensitivity proteins, similar to control B1-8f/glD42i mice (depicted and B1-8/JHT control mice (data not shown). In contrast, a large proportion (56%) of the IgM lo cells (fraction b) in the mesenteric lymph node of B1-8f/J H T, Mx-cre mice 5 days after IFN treatment have decreased FSC, suggesting that they are apoptotic cells. In addition, a new population of cells (fraction c) is also detected in these mice in which essentially all cells (87%) appear to be apoptotic as indicated by their reduced size. This population is not found in control mice treated with IFN ( Figure  5A ) or PBS (data not shown). As a further internal control, most of the remaining IgM hi cells (fraction a) in the IFNtreated B1-8f/JHT, Mx-cre mice have a normal FSC profile similar to the viable lymphocytes in control mice.
Another characteristic of apoptotic cells is the loss of cell membrane phospholipid asymmetry (Martin et al., 1995) . This can be detected by flow cytometry using Annexin V (Koopman et al., 1994) , which binds phospha- days after IFN injection, low levels of Annexin V-positive cells (approximately 7% of total splenocytes) were found for PBL in Figure 4 ). However, 9 days after IFN induction, in the spleen of B1-8f/JHT, Mx-cre mice ( Figure 5B ). a population of IgH b "only" B cells can be seen in lymph These cells, however, increase 2-to 3-fold in number nodes (Figure 4) , spleen, and peritoneal cavity of B1-8f/ (to approximately 20% of total splenocytes) 6 days after glD42i, Mx-cre mice (data not shown). These are likely IFN treatment. In comparison, approximately 5% of the peripheral B cells that have deleted the B1-8f allele but cells from control B1-8f/J H T mice 6 days after IFN injecremained viable as they possess a second BCR. They tion were Annexin V-positive. Further staining of these are not newly generated single IgH-expressing B cells various samples revealed that only approximately 15% that have emigrated from the bone marrow, as B lymphoof the Annexin V-positive cells were PI-positive, indicatpoiesis in these mice had been blocked by prior treating that most of these cells are indeed apoptotic cells ment of anti-IL7R MAb. This was confirmed by flow (data not shown). Concomitant with the increase in cytometric analysis of bone marrow cells from these Annexin V-positive cells, there was a decrease in the mice that revealed the absence of a discrete population level of IgM ϩ cells in these IFN-treated B1-8f/J H T, Mx-cre of immature B cells (data not shown).
mice. Forty-five days after IFN injection in B1-8f/JHT, Quantification of Ig ϩ B cells in the various lymphoid Mx-cre mice, at a time when B cells with deleted B1-8f organs of IFN-treated B1-8f/glD42i, Mx-cre mice showed allele have disappeared (see Figure 3) , the fraction of that there was no reduction in the number of B cells Annexin V-positive cells is again at background level. as compared to control B1-8f/glD42i mice that were Taken together, these data indicate that apoptotic similarly treated (data not shown). Thus, double IgHcells can be detected in situ in IFN-treated B1-8f/J H T, expressing B cells that lose one BCR survive as single Mx-cre mice and suggest that mature B cells are likely producers in the periphery.
to undergo apoptosis upon loss of BCR expression.
Receptorless B Cells Likely Undergo
Apoptotic Cell Death Constitutive bcl-2 Expression Delays the Death of Receptorless B Cells Cells undergoing apoptosis are characterized by nuclear chromatin condensation, size reduction, membrane blebPrevious studies have shown that the protein encoded by the mammalian proto-oncogene bcl-2 can prevent bing, and finally, DNA degradation (Wyllie et al., 1980) . We used some of these parameters to examine B cells apoptotic cell death caused by a variety of stimuli and enhance the survival of many cell types, including both losing BCR for signs of apoptosis.
Cell size is usually measured as forward scatter (FSC) immature and mature B lymphocytes, in vitro and in vivo (Vaux et al., 1988; McDonnell et al., 1989 ; Strasser et in flow cytometry. Accordingly, apoptotic cells can be detected as cells with reduced FSC compared to their al., 1991). Bcl-2 transgene expression has also been shown to delay the elimination of autoreactive B cells viable counterparts (Darzynkiewicz et al., 1991) . As seen in Figure 5A , cells that express a high level of surface (Hartley et al., 1993) . This is of particular relevance to the present study, as similar cellular mechanisms may IgM (IgM hi , fraction a) in the mesenteric lymph node of IFN-injected B1-8f/J H T control mice have a well-defined operate to eliminate autoreactive and nonfunctional B cells. We therefore assessed whether constitutive bcl-2 FSC profile, typical of viable lymphocytes. This is also true for the IgM hi cells in PBS-injected B1-8/J H T, Mx-cre expression can rescue receptorless B cells from apo- ptotic cell death by introducing the E-bcl-2-22 transin control B1-8f/ϩ, bcl-2tg mice in the various lymphoid organs examined except the peritoneal cavity. Together, gene (Strasser et al., 1991) into B1-8f/ϩ, Mx-cre mice.
In the analyses presented in Figure 6 and Table 1 , they represent only 50%-60% of the fraction of B-lineage cells found in control animals. Thus, it appears heterozygous mice (IgH B1-8f, a/ϩ, b ) were used. In these B1-8f/ϩ, Mx-cre and B1-8f/ϩ, Mx-cre, bcl-2tg mice, that bcl-2 transgene expression delays but does not prevent the disappearance of receptorless B cells. This bone marrow B cells could rearrange their wild-type IgH allele upon IFN-induced deletion of the B1-8f allele.
is evident in Figure 6 , which shows the presence of a distinct population of B220 ϩ IgM Ϫ cells in B1-8f/ϩ, MxThus, to get a more accurate representation of the effect of bcl-2 transgene expression on cell survival, IgH bcre, bcl-2tg mice 10 days after IFN injection (middle panel) but no longer at a later time point (18 days, bottom expressing B cells (i.e., cells that have rearranged the wild-type allele) were excluded from the analysis. panel). Ten days after IFN induction, a substantial fraction of B220 ϩ IgM Ϫ cells is present in the spleen ( Figure 6 ) as
Loss of BCR Expression Results in Distinct
Phenotypic Changes on B Cells well as in lymph nodes and peritoneal cavity (data not shown) of B1-8f/ϩ, Mx-cre, bcl-2tg mice. Such a populaTo examine whether the loss of BCR expression could affect the expression of other surface molecules, we tion is hardly detectable in similarly treated B1-8f/ϩ, Mx-cre and various other control mice ( Figure 6 chains are secreted or degraded in the absence of IgH and CD40, which are molecules involved in the activachains (Dul et al., 1996) . This argues against the possibiltion of B cells, were also expressed at equivalent levels ity that the disappearance of B cells that have deleted between IgM lo and IgM hi cells in these mice, as were the the B1-8f allele is due to the accumulation of uncomadhesion molecules CD49d (alpha 4 integrin), CD62L plexed L chains in the cytoplasm that could be toxic to (L-Selectin), and integrin ␤7 chain (data not shown). the cells.
Interestingly, major histocompatibility complex (MHC) Several cell surface molecules have been implicated Class I and Class II antigens, molecules involved in the in the modulation of BCR signaling. Of these, CD19, presentation of peptides to T cells, were down-regulated CD38, and CD45 (B220) were found to be expressed at control mice did not have increased level of Fas expres- (Strasser et al., 1994) showing that constitutive bcl-2 expression leads to the accumulation of sIgM Ϫ B cells sion. Thus, the loss of BCR expression on mature B cells leads to an increased level of Fas expression.
with mature phenotype in severe combined immunodeficiency (scid) mice in which the assembly of V region Taken together, the results suggest that the loss of BCR expression on mature B lymphocytes induces the genes is genetically impaired. However, the scid phenotype is "leaky" (Bosma and Carroll, 1991) in that V region cells to selectively modulate the expression of certain cell surface molecules. These specific changes could gene rearrangements occasionally occur in the progenitor population. Thus, the sIgM Ϫ B cells observed by in turn influence the fate of these cells. Strasser et al. (1994) may represent the progeny of rare progenitors that have acquired in-frame V region gene Discussion rearrangements, migrated to the periphery, undergone isotype switching, and accumulated due to excessive Essential Role of the BCR in Developing antigenic stimulation. Indeed, this seems likely as conand Mature B Cells stitutive bcl-2 expression did not lead to an accumulaThe expression of a functional pBCR and, later, BCR is tion of sIgM Ϫ B cells with mature phenotype in recombicentral for early B cell development . nation-deficient (Rag2 Ϫ/Ϫ ) mice (Young et al., 1997) . Thus, in mouse mutants unable to express a pBCR, B Thus, even if survival signals through the BCR result in cell development is blocked at the pro-B cell stage of bcl-2 up-regulation, the latter alone is not sufficient for differentiation (Kitamura et al., 1991 Shinkai et al., 1992) but can be rescued by
The distinct changes of cell surface phenotype obthe introduction of functional immunoglobulin L and/or served in B cells that lose BCR expression suggest that H chain transgenes (Spanopoulou et al., 1994 ; Young the immune system may have evolved strategies in addi Pelanda et al., 1996) . Similarly, when the tion to cell-autonomous apoptosis, to ensure the elimiexpression or signaling competence of a pBCR and/or nation of nonfunctional B lymphocytes. Thus, the up-BCR is compromised, cells are eliminated at the pre-B regulation of Fas expression on receptorless B cells cell stage of development or are prevented from seeding could render these cells susceptible to T cell-mediated the peripheral immune system (Gong and Nussenzweig killing, in analogy to the putative elimination of autoreac-1996; Torres et al., 1996) . We now show that mature B tive B cells through a Fas-Fas ligand (FasL)-mediated cells, having passed through these early checkpoints in mechanism (Rathmell et al., 1995) . In this process, T development and selected into the long-lived peripheral cell-derived signals, initiated by CD40-CD40 ligand pool, still depend on the expression of BCR for their (CD40L) interaction, finally result in Fas-mediated B cell persistence. Ablation of BCR leads to death of mature death, unless the cells are rescued by coactivation B cells. Thus, the data presented in this paper build through the T cell antigen receptor, a reaction that deupon the basic principle of B cell development, namely, pends on antigen processing via the BCR (Rathmell et that B lymphocytes are continuously being selected for al., 1996). Thus, it is possible that BCR ablation deprives their ability to express a functional antibody and that B cells of a signal to suppress Fas up-regulation caused nonfunctional B cells and their progenitors are rapidly by CD40-CD40L interaction, thereby making them tarremoved from the immune system. gets of cytotoxic T cells (Rothstein et al., 1995; Lagresle et al., 1996) . Experiments are now underway to test this Elimination of Receptorless B Cells possibility by crossing B1-8f/ϩ, Mx-cre with T cellWhy are mature B cells devoid of BCR not maintained deficient (Mombaerts et al., 1991) , Fas-deficient, and in the peripheral immune system? The most straightfor-CD40L-deficient (Xu et al., 1994) mice. ward interpretation of this phenomenon is that the BCR Similarly, the down-regulation of MHC class I antigens provides a survival signal to these cells. Such a signal on receptorless B cells could make them targets for could be B cell-autonomous and depend upon the asnatural killer (NK) cells. Murine MHC class I molecules sembly of the BCR complex as such (Reth and Wie- have been shown to interact with the Ly-49 receptors nands, 1997) or its interaction with other molecules on expressed on subsets of NK cells and inactivate NK the B cell surface. Alternatively, B cell survival could be cell-mediated cytotoxiciy (Karlhofer et al., 1992) . NK mediated by low level signals generated by (low affinity?) cell-mediated elimination of cells lacking MHC class I interaction of the BCR with self or environmental antimolecules has been demonstrated for certain tumor gens. This relates to the old and still unresolved problem cells (Kä rre et al., 1986) and normal lymphoblasts from of whether B cells, in analogy to T cells (Kisielow and ␤2-microglobulin-deficient mice (Liao et al., 1991). von Boehmer, 1995; Takeda et al., 1996) , require ligandWhether NK cells indeed contribute to the elimination mediated positive selection for their entry and persisof nonfunctional B lymphocytes awaits future experitence in the peripheral immune system (Gu et al., 1991;  ments in which one would deplete NK cells in vivo. Schwartz and Stollar, 1994) . Further insights into these matters could come from analyses of the downstream components of the signaling chain leading to B cell A Common Mechanism for the Elimination of Useless and Potentially elimination as described here, again using inducible gene targeting.
Harmful B Cells?
While the present system of induced BCR ablation is It is interesting to note that constitutive bcl-2 expression was unable to fully rescue receptorless B cells from artificial, B cells losing BCR expression must naturally arise through spontaneous somatic mutation, and at apoptosis. This seems to contradict a previous report the targeted and wild-type IgH alleles were 2.7 and 3.6 kb, respechigh rate, through somatic hypermutation in the germitively. Of 100 double drug-resistant ES cell clones, 12 were identified nal center reaction that is the basis of the generation as homologous recombinants and confirmed by Southern blotting of high affinity B cell memory a self-antigen (Hartley et al., 1993 elimination when they compete with wild-type cells (Hartley et al., 1993; Cyster et al., 1994) . Useless and poten-
Mouse Strains
tially harmful B cells may thus be eliminated by a similar
The Mx-cre (Kü hn et al., 1995) , J H T (Gu et al., 1993) and glD42i mechanism. This raises the interesting possibility that (Sonoda et al., 1997) mice used in this study were bred and mainalso a mechanism of cellular rescue, namely the genera- Han et al. 1996; Hikida et al., 1996) , its possible B1-8f/ϩ mice were crossed with Mx-cre (Kü hn et al., 1995) mice or sequentially with J HT/JHT (Gu et al., 1993) and Mx-cre mice to generinitiation upon BCR ablation in the present system reate B1-8f/ϩ, Mx-cre or B1-8f/JHT, Mx-cre mice. These transgenic mains to be investigated.
mice were genetically a mixture of strains 129, CB20, and C57BL/6. For the induction of Cre expression and subsequent deletion of BCR, mice were given three doses of recombinant ␣/␤ IFN (2 ϫ 10 6
Experimental Procedures U/dose) intravenously on days 0, 3, and 6 and analyzed at various time points thereafter. Control mice were given PBS. For the analysis Construction of the B1-8VDJE f Targeting Vector of double IgH-expressing B cells, B1-8f/glD42, Mx-cre and B1-8f/ The construction of the targeting vector consisted of a modification glD42 control mice were first given two doses of 1 mg of anti-IL7R of the short arm of homology of the vector pIVhL2neo r (Sonoda et MAb (A7R34) intravenously to inhibit B lymphopoiesis in the bone al., 1997). A 1.1 kb fragment containing the E enhancer was amplimarrow (Sudo et al., 1993) . One week later, the mice were treated fied by polymerase chain reaction (PCR) from genomic DNA of 129/ with IFN as above for the induction of B1-8f allele deletion and Ola-derived E14.1 ES cell line using primers 5Ј-TGTCTATCGATCTC analyzed 9 days later. AGAGGC-3Ј and 5Ј-CGGGAAGCTTGAACTACTCAA-3Ј. This fragment
To assess the degree of B1-8f gene deletion, cells were isolated was cloned into plasmid pKL-1 that contains a single loxP site to from different organs of B1-8f/J H T, Mx-cre mice at various time derive plasmid pKL-2. A second 1.1 kb intronic fragment downpoints after IFN injection for Southern blot analysis. Splenic lymphostream of the E enhancer and including the 3Ј Matrix Attachment cytes were further separated into B and non-B cells by MACS (MilRegion was amplified using primers 5Ј-CTTGAATTCGGACTTTAGT tenyi) using anti-CD43 MAb-coupled magnetic beads. The purity of CTCTTTAATT-3Ј and 5Ј-ACATCTAGAGAGTTGTAGATCAAGAATG-3Ј B cells obtained by this procedure is usually Ͼ90%. and cloned into pBluescript to obtain pKL-3. Subsequently, a 2 kb SalI-HindIII fragment containing the B1-8VDJ and the 1.2 kb Flow Cytometry HindIII-EcoRI fragment containing the E enhancer and a single Cells obtained from the various lymphoid organs of mice were loxP site was cloned into EcoRI-SalI-digested pKL-3 in a threestained with fluorochrome (fluorescein isothiocyanate, FITC; phyway ligation to obtain pKL-4. Finally, the loxP-flanked B1-8VDJE coerythrin, PE) or biotin-conjugated monoclonal antibodies for flow fragment was excised as a XhoI-NotI fragment and cloned into cytometric analyses on a FACScan (Becton Dickinson). Biotin-conpIVhL2neo r to generate the B1-8VDJE f targeting vector. MAbs to the following cell surface antigens were purchased from that of published protocols (Torres and Kü hn, 1997) . E14.1 ES cells Pharmingen: CD3, CD19, CD24, CD38, CD40, CD62L, CD69, and (1 ϫ 10 7 ) were transfected with NotI-linearized targeting vector (30 CD95 (Fas) . g) by electroporation and selected with G418 (350 g/ml) and Gancyclovir (2 M). Double resistant colonies were identified by PCR using a 5Ј primer (5Ј-CAAGGCACCACTCTCACAGTCT-3Ј) that Apoptotic Cell Assays Apoptotic B cells were identified ex vivo by Annexin V (Boehringer anneals to the JH2 element in the B1-8VDJ and a 3Ј primer that is located external to the targeting construct (5Ј-TGTGGATCCAGACT Mannheim) staining in flow cytometric analyses. Cells were stained according to the manufacturer's instructions. TAGTCCAGCCG-3Ј). The expected sizes of the PCR fragments from
